Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dyadic International (NQ: DYAI )

3.220 +0.170 (+5.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,092
Open 3.040
Bid (Size) 1.400 (2)
Ask (Size) 3.240 (9)
Prev. Close 3.050
Today's Range 2.850 - 3.360
52wk Range 1.742 - 6.890
Shares Outstanding 28,264,157
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Dyadic International Q1 Earnings
Dyadic International (NASDAQ:DYAI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
India Funds Affordable COVID-19 Vaccine Candidate Using Dyadic's Platform
 
Via Benzinga

Performance

YTD
-33.06%
-33.06%
1 Month
+43.11%
+43.11%
3 Month
-0.92%
-0.92%
6 Month
-23.70%
-23.70%
1 Year
-12.26%
-12.26%

More News

Read More
Dyadic International Earnings Perspective: Return On Capital Employed
Via Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Via Benzinga
A Preview Of Dyadic International's Earnings
Via Benzinga
Why Phibro Shares Are Trading Higher Today?
Via Benzinga
Earnings Scheduled For March 29, 2022
Via Benzinga
This Vaccine Stock Is Now On Janssen Pharmaceuticals, J&J, The White House's Radar
Via Talk Markets
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
63 Biggest Movers From Friday
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Via Benzinga
This Company has its Sights Set of Transforming the Pharmaceutical Industry With its Efficient C1 Vaccine & Drug Manufacturing Technology
Via Benzinga
Dyadic International Earnings Perspective: Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Market Briefing For Thursday, Aug. 26
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
Via Talk Markets
Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
From Dyadic International, Inc.
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.